Catalyst

Slingshot members are tracking this event:

Deleware Court Rules Actavis Labs' (TEVA) Abbreviated New Drug Application (ANDA) for Generic Version of Pain Med Zohydro ER Infringes on Two of Pernix' (PTX) Patents

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TEVA

100%
PTX

100%
Actavis Labs

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 23, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Abbreviated New Drug Application, Anda, Generic Version, Pain Med, Zohydro Er, Patent Infringement